Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia

BACKGROUND: Treatment choice in pediatric immune thrombocytopenia (ITP) is arbitrary, because few studies are powered to identify predictors of therapy response. Increasingly, rituximab is becoming a treatment of choice in those refractory to other therapies. METHODS: The objective of this study was...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Grace, Rachael F., Bennett, Carolyn M., Ritchey, A. Kim, Jeng, Michael, Thornburg, Courtney D., Lambert, Michele P., Neier, Michelle, Recht, Michael, Kumar, Manjusha, Blanchette, Victor, Klaassen, Robert J., Buchanan, George R., Kurth, Margaret Heisel, Nugent, Diane J., Thompson, Alexis A., Stine, Kimo, Kalish, Leslie A., Neufeld, Ellis J.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3863944/
https://ncbi.nlm.nih.gov/pubmed/21674758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23130
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires